Related Experiment Video
Updated: Jul 5, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Evaluating competing adverse and beneficial outcomes using a mixture model.
Bryan Lau1, Stephen R Cole, Richard D Moore
1Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA. blau1@jhmi.edu
This study introduces a mixture model to analyze competing risks, estimating adverse-benefit ratios and subhazard ratios. The methods are applied to HIV data to compare treatment discontinuation risks versus treatment benefits.
Area of Science:
- Biostatistics
- Epidemiology
- Clinical Research Methodology
Background:
- Competing risks are common in clinical studies, where standard survival analysis can overestimate event incidence.
- Mixture models offer a way to analyze subdistributions in competing risk scenarios.
- Interventions may involve balancing adverse events against beneficial outcomes.
Purpose of the Study:
- To present methods for estimating adverse-benefit ratio curves and subhazard ratios using mixture models.
- To compare the risk of antiretroviral discontinuation/switching against HIV RNA suppression in an HIV cohort.
Main Methods:
- Utilized a mixture model framework for competing risk analysis.
- Developed parametric approaches for estimating adverse-benefit ratio curves and subhazard ratios.
- Considered extensions for event type uncertainty, left truncation, and interval censoring.
Main Results:
- Demonstrated the application of the mixture model to HIV clinical cohort data.
- Estimated the adverse-benefit ratio curve and subhazard ratios for competing events.
Conclusions:
- Mixture models provide a robust framework for analyzing competing risks, particularly for comparing adverse events to beneficial outcomes.
- The presented methods offer valuable tools for clinical research, allowing for nuanced comparisons of event risks.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Methods of Medium Optimization
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
